Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 | Zendy

Wesley H. Self | Zendy; Matthew W. Semler | Zendy; Lindsay Leither | Zendy; Jonathan D. Casey | Zendy; Derek Angus | Zendy; Roy G. Brower | Zendy; Steven Y. Chang | Zendy; Sean P. Collins | Zendy; John Eppensteiner | Zendy; Michael R. Filbin | Zendy; D. Clark Files | Zendy; Kevin W. Gibbs | Zendy; Adit A. Ginde | Zendy; Michelle N. Gong | Zendy; Frank E. Harrell | Zendy; Ivor S. Douglas | Zendy; Catherine L. Hough | Zendy; Nicholas J. Johnson | Zendy; Akram Khan | Zendy; Christopher J. Lindsell | Zendy; Michael A. Matthay | Zendy; Marc Moss | Zendy; Pauline K. Park | Zendy; Todd W. Rice | Zendy; Bryce R. H. Robinson | Zendy; David Schoenfeld | Zendy; Nathan I. Shapiro | Zendy; Jay S. Steingrub | Zendy; Christine A. Ulysse | Zendy; Alexandra Weissman | Zendy; Donald M. Yealy | Zendy; Bruce Thompson | Zendy; Samuel M. Brown | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19

Author(s) -

Wesley H. Self,

Matthew W. Semler,

Lindsay Leither,

Jonathan D. Casey,

Derek Angus,

Roy G. Brower,

Steven Y. Chang,

Sean P. Collins,

John Eppensteiner,

Michael R. Filbin,

D. Clark Files,

Kevin W. Gibbs,

Adit A. Ginde,

Michelle N. Gong,

Frank E. Harrell,

Ivor S. Douglas,

Catherine L. Hough,

Nicholas J. Johnson,

Akram Khan,

Christopher J. Lindsell,

Michael A. Matthay,

Marc Moss,

Pauline K. Park,

Todd W. Rice,

Bryce R. H. Robinson,

David Schoenfeld,

Nathan I. Shapiro,

Jay S. Steingrub,

Christine A. Ulysse,

Alexandra Weissman,

Donald M. Yealy,

Bruce Thompson,

Samuel M. Brown

Publication year - 2020

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2020.22240

Subject(s) - medicine , hydroxychloroquine , interim analysis , placebo , odds ratio , randomized controlled trial , randomization , severity of illness , clinical trial , pediatrics , covid-19 , disease , alternative medicine , pathology , infectious disease (medical specialty)

Data on the efficacy of hydroxychloroquine for the treatment of coronavirus disease 2019 (COVID-19) are needed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research